Insights

Gathering insights about Orchard…

Similar companies to Orchard

Roku Inc.
$1B$10B

Orchard Tech Stack

Media & News

Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
Newborn screening is the only practical means of diagnosing MLD prior to the onset of symptoms, which is key to achieving optimal outcomes for children and their families with this rapidly progressive disease
Dec 16, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Completion of enrollment achieved nearly one year ahead of schedule Primary analysis anticipated two years post-treatment TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of OTL-203, an investigational hematopoietic stem cell (HSC) gene therapy, in patients with the Hurler subtype of mucopolysaccharidosis type I (MPS-IH). The trial (NCT06149403), referred to as HURCULES, compares treatment with OTL-203 to standard of care with allogeneic hematopoietic stem cell transplant (allo-HSCT).
Jul 07, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Reimbursement Agreement in Spain
LONDON, MADRID, and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it has recently reached an agreement with the Interministerial Commission for the Pricing of Medicines of the Directorate of Common Portfolio of Services of the Spanish National Health System (SNS) which will result in reimbursed access to Libmeldy® (atidarsagene autotemcel) for all eligible children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ) or early symptomatic early juvenile (ESEJ)—collectively referred to as early-onset—metachromatic leukodystrophy (MLD).
Feb 28, 2025 | www.globenewswire.com
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food and Drug Administration approval last year
Feb 12, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS
Feb 03, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Multiple Data Presentations and Publications
Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company's platform in rare neurometabolic diseases and beyond
Oct 23, 2024 | www.globenewswire.com
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
ISTANBUL and LONDON, and BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe and Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced the companies have signed an exclusive distribution agreement to commercialize Libmeldy® (atidarsagene autotemcel), the only approved therapy for eligible children with early-onset metachromatic leukodystrophy (MLD).
Oct 07, 2024 | www.globenewswire.com

Orchard's Email Address Formats

Orchard uses at least 2 format(s):

Orchard Email Formats	Example	Percentage
First@lightningorchard.com	John@lightningorchard.com	100%
First@orchardcreative.com	John@orchardcreative.com	100%

Frequently Asked Questions

Where is Orchard's headquarters located?

Orchard's main headquarters is located at 20 Jay Street #1100 Brooklyn, New York United States. The company has employees across 1 continents, including North America.

What is Orchard's stock symbol?

Orchard is a publicly traded company; the company's stock symbol is ORTX.

What is Orchard's official website and social media links?

Orchard's official website is orchardcreative.com and has social profiles on LinkedIn.

What is Orchard's SIC code NAICS code?

Orchard's SIC code is 8742 - Management Consulting Services NAICS code is 541613 - Marketing Consulting Services.

How many employees does Orchard have currently?

As of March 2026, Orchard has approximately 35 employees across 1 continents, including North America. Key team members include Chief Creative Officer: D. K.Head Of Strategy: K. M.Head Of Strategy: S. G.. Explore Orchard's employee directory with LeadIQ.

What industry does Orchard belong to?

Orchard operates in the Advertising Services industry.

What is Orchard's email format?

Orchard's email format typically follows the pattern of First@lightningorchard.com. Find more Orchard email formats with LeadIQ.

When was Orchard founded?

Orchard was founded in 2019.

Orchard

Q: What is Orchard's official website and social media links?

Orchard's official website is orchardcreative.com. Orchard has social profiles on LinkedIn.

Q: How many employees does Orchard have currently?

Orchard has approximately 35 employees.

Advertising ServicesNew York, United States11-50 Employees

Welcome to Orchard. We are a fully independent, strategically led creative agency. 

Our agency teams consist of a strategist and creative working in partnership together from the very beginning (research and brief development) to the very end (production). 

Clients describe our process and approach to advertising in one simple word: refreshing.

Campaign Agency of the Year Shortlist: 2026
The Drum World's Hottest Independent Agencies 2025
AdAge A-List 2024 & 2023
Adweek Agency of the Year Finalist 2023
Adweek Creative 100 2023: David Kolbusz, CCO
Inc. Best In Business 2021: Gold
AdAge Leading Women 2021: Laura Janness, CSO
Campaign US Agency of The Year 2020: Independent Agencies
Campaign Global Agency of The Year 2020: Independent Agencies

see less